Benjamin Pariente (B Pariente)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 13

Top Topics

Hidradenitis Suppurativa

Ulcerative Colitis

Clinical Decision Support

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Pauline Wils, Benjamin Pariente
Editorial: keep calm and carry on-managing non-TNF antagonist biologics in pregnancy-authors' reply. Alimentary pharmacology & therapeutics 53 (3) (2021)
Clémentine Lauriot Dit Prevost, Mustapha Azahaf, Maria Nachury, Julien Branche, Romain Gerard, Pauline Wils, Thomas Lambin, Pierre Desreumaux, Olivier Ernst, Benjamin Pariente
Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index. Alimentary pharmacology & therapeutics 51 (9) (2020)
Benjamin Pariente
Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience. Author's reply. Alimentary pharmacology & therapeutics 51 (11) (2020)
Pauline Wils, Philippe Seksik, Carmen Stefanescu, Stephane Nancey, Matthieu Allez, Guillaume Pineton de Chambrun, Romain Altwegg, Cyrielle Gilletta, Lucine Vuitton, Stéphanie Viennot, Mélanie Serrero, Mathurin Fumery, Guillaume Savoye, Michael Collins, Felix Goutorbe, Hedia Brixi, Guillaume Bouguen, Noémie Tavernier, Medina Boualit, Aurélien Amiot, Vered Abitbol, David Laharie, Benjamin Pariente, null null
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Alimentary pharmacology & therapeutics 53 (4) (2020)
Aurélien Amiot, Jérôme Filippi, Vered Abitbol, Guillaume Cadiot, David Laharie, Melanie Serrero, Romain Altwegg, Yoram Bouhnik, Laurent Peyrin Biroulet, Cyrielle Gilletta, Xavier Roblin, Guillaume Pineton de Chambrun, Lucine Vuitton, Anne Bourrier, Stephane Nancey, Jean-Marc Gornet, Stephane Nahon, Guillaume Bouguen, Stephanie Viennot, Benjamin Pariente, Mathurin Fumery, null null
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study. Alimentary pharmacology & therapeutics 51 (11) (2020)
Parambir S Dulai, Aurelien Amiot, Laurent Peyrin Biroulet, Vipul Jairath, Melanie Serrero, Jerome Filippi, Siddharth Singh, Benjamin Pariente, Edward V Loftus, Xavier Roblin, Sunanda Kane, Anthony Buisson, Corey A Siegel, Yoram Bouhnik, William J Sandborn, Karen Lasch, Maria Rosario, Brian G Feagan, Daniela Bojic, Caroline Trang-Poisson, Bo Shen, Romain Altwegg, Bruce E Sands, Jean Frederic Colombel, Franck Carbonnel, null null
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease. Alimentary pharmacology & therapeutics 51 (5) (2019)
Aurélien Amiot, Melanie Serrero, Laurent Peyrin Biroulet, Jerome Filippi, Benjamin Pariente, Xavier Roblin, Anthony Buisson, Carmen Stefanescu, Caroline Trang-Poisson, Romain Altwegg, Philippe Marteau, Thibaud Vaysse, Anne Bourrier, Stephane Nancey, David Laharie, Matthieu Allez, Guillaume Savoye, Jacques Moreau, Lucine Vuitton, Stephanie Viennot, Guillaume Bouguen, Vered Abitbol, Mathurin Fumery, Charlotte Gagniere, Yoram Bouhnik, null null
Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study. Alimentary pharmacology & therapeutics 50 (1) (2019)
Benjamin Pariente, A Blondeaux
Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first line therapy in inflammatory bowel disease. Alimentary pharmacology & therapeutics 48 (6) (2019)
Michael Génin, Mathurin Fumery, Florent Occelli, Guillaume Savoye, Benjamin Pariente, Luc Dauchet, Jonathan Giovannelli, Cécile Vignal, Mathilde Body-Malapel, Hélène Sarter, Corinne Gower-Rousseau, Grégoire Ficheur
Fine-scale geographical distribution and ecological risk factors for Crohn's disease in France (2007-2014). Alimentary pharmacology & therapeutics 51 (1) (2019)
P Wils, Y Bouhnik, Pierre Michetti, B Flourie, H Brixi, A Bourrier, M Allez, B Duclos, M Serrero, Anthony Buisson, Aurélien Amiot, M Fumery, Xavier Roblin, Laurent Peyrin Biroulet, J Filippi, Guillaume Bouguen, V Abitbol, B Coffin, M Simon, David Laharie, Benjamin Pariente, null null
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience. Alimentary pharmacology & therapeutics 47 (5) (2018)
Charlotte Gagnière, Anne Bourrier, Philippe Seksik, Jean-Marc Gornet, Olivier DeWit, Stephane Nancey, Romain Altwegg, Vered Abitbol, David Laharie, Catherine Reenaers, Anthony Buisson, Benjamin Pariente, Stephanie Viennot, Lucine Vuitton, Carmen Stefanescu, Philippe Marteau, Guillaume Bouguen, Jacques Cosnes, Aurélien Amiot, null null
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Alimentary pharmacology & therapeutics 48 (7) (2018)
S-C Sacleux, H Sarter, M Fumery, C Charpentier, N Guillon-Dellac, H Coevoet, Benjamin Pariente, Laurent Peyrin Biroulet, C Gower-Rousseau, G Savoye, null null
Post-operative complications in elderly onset inflammatory bowel disease: a population-based study. Alimentary pharmacology & therapeutics 47 (12) (2018)
S Tadbiri, Laurent Peyrin Biroulet, M Serrero, J Filippi, Benjamin Pariente, Xavier Roblin, Anthony Buisson, C Stefanescu, C Trang-Poisson, R Altwegg, P Marteau, T Vaysse, A Bourrier, S Nancey, D Laharie, M Allez, G Savoye, C Gilletta, C Gagniere, L Vuitton, S Viennot, A Aubourg, A-L Pelletier, G Bouguen, V Abitbol, M Fumery, P Claudepierre, Y Bouhnik, Aurélien Amiot, null null
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort. Alimentary pharmacology & therapeutics 47 (4) (2017)